Synovial Sarcoma Clinical Trials

59 clinical trials for Synovial Sarcoma across international registries, including 14 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• SPEARHEAD-3 Pediatric Study — RECRUITING · PHASE1
• NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) — RECRUITING · PHASE1
• Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1 — RECRUITING · PHASE1
• Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors — RECRUITING · PHASE1
• N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy — RECRUITING · PHASE1
• Synovial Sarcoma Registry / Biospecimen Repository — RECRUITING
• START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer — RECRUITING · PHASE1
• Personalized Vaccination in Fusion+ Sarcoma Patients (PerVision) — RECRUITING · PHASE1
• Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS) — RECRUITING · PHASE3
• HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma — RECRUITING · PHASE1
• ACTengine® IMA203 Combined With mRNA-4203 — RECRUITING · PHASE1
• MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma — RECRUITING · PHASE2
• Pasireotide as Maintenance Treatment in Synovial Sarcoma and Desmoplastic Small Round Cell Tumor — RECRUITING · PHASE2
• A PHASE 2 SINGLE ARM OPEN-LABEL CLINICAL TRIAL OF ADP-A2M4 SPEAR T CELLS IN SUBJECTS WITH ADVANCED SYNOVIAL SARCOMA OR MYXOID/ROUND CELL LIPOSARCOMA (SPEARHEAD 1 STUDY) — RECRUITING · PHASE2
• Expanded Access Protocol (EAP) for Nonconforming (NC) Afami-cel — OTHER
• Tazemetostat Expanded Access Program for Adults With Solid Tumors — TERMINATED
• Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery — COMPLETED · PHASE2
• MAGE-A4ᶜ¹º³²T for Multi-Tumor — ACTIVE_NOT_RECRUITING · PHASE1
• B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults — ACTIVE_NOT_RECRUITING · PHASE1
• Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma — ACTIVE_NOT_RECRUITING · PHASE1
• Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma Patients — COMPLETED · NA
• Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma — ACTIVE_NOT_RECRUITING · PHASE2
• Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults — ACTIVE_NOT_RECRUITING · PHASE1
• A Study to Assess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated With Tazemetostat in a Previous Clinical Study — COMPLETED · PHASE1
• A Study of Tazemetostat in Adult Participants With Soft Tissue Sarcoma — COMPLETED · PHASE2
• Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels — COMPLETED · PHASE1
• EPITOME-1015-I: a Study to Investigate the Safety and Tolerability of MDG1015 in Patients with Epithelial Ovarian Cancer, Gastroesophageal Adenocarcinoma, Round Cell Liposarcoma And/or Synovial Sarcoma — NOT_YET_RECRUITING · PHASE1
• The Registry of Oncology Outcomes Associated With Testing and Treatment — COMPLETED
• A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors — TERMINATED · PHASE1
• Study of TBI-1301 (NY-ESO-1 T Cell Receptor Gene Transduced Autologous T Lymphocytes) in Patients with Synovial Sarcoma — COMPLETED · PHASE1
• EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma — COMPLETED · PHASE1
• Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors — TERMINATED · PHASE1
• Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma — NOT_YET_RECRUITING · NA
• Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma — COMPLETED · PHASE2
• CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Synovial Sarcoma — TERMINATED · PHASE1
• NY-ESO-1-redirected CRISPR (TCRendo and PD1) Edited T Cells (NYCE T Cells) — TERMINATED · PHASE1
• A Study of Anti-CTLA-4 Antibody in Patients With Advanced Synovial Sarcoma — TERMINATED · PHASE2
• Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma — WITHDRAWN · PHASE2
• A Phase 2 Study of 9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced Sarcomas — WITHDRAWN · PHASE2
• Whole Lung IMRT in Children and Adults With Synovial Sarcoma and Lung Metastases — COMPLETED · PHASE2
• Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas — OTHER · PHASE2
• Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall — OTHER · PHASE2
• Study to Compare the Safety and Efficacy of CMB305 With Atezolizumab to Atezolizumab Alone in Participants With Sarcoma (IMDZ-C232/V943A-002) — TERMINATED · PHASE2
• A Phase 3, Randomized, Double-blind, Placebo-controlled Study For Subjects With Locally-advanced Unresectable or Metastatic Synovial Sarcoma (V943-003, IMDZ-04-1702) — TERMINATED · PHASE3
• Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies — OTHER · PHASE1
• Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts After Intensive Chemotherapy — COMPLETED · PHASE1
• DHEA in Synovial Sarcoma Patients — TERMINATED · PHASE1
• Recombinant Interferon Gamma in Treating Patients With Soft Tissue Sarcoma — TERMINATED · PHASE1
• Study on Leiomyosarcoma, Liposarcomas and Synovial Sarcoma With Trabectedin — WITHDRAWN · PHASE3

Refine this search